A new acidic myotoxic, anti-platelet and prostaglandin I2 inductor phospholipase A2 isolated from Bothrops moojeni snake venom

Toxicon

Volumn 52, Issue 8, 2008, Pages 908-917

  Santos Filho, Norival A ^a   Silveira, Lucas B ^a   Oliveira, Clayton Z ^a   Bernardes, Carolina P ^a   Menaldo, Danilo L ^a   Fuly, André L ^b   Arantes, Eliane C ^a   Sampaio, Suely V ^a   Mamede, Carla C N ^c   Beletti, Marcelo E ^c   de Oliveira, Fábio ^c   Soares, Andreimar M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Acidic phospholipase A2; Bothrops moojeni; Chemical modification; Myotoxin; Platelet aggregation inhibitor; Prostaglandin I2 inductor; Snake venom

Indexed keywords

ADENOSINE DIPHOSPHATE; ASPARTIC ACID; BMOOTX 1 ENZYME; COLLAGEN; PHOSPHOLIPASE A2; SNAKE VENOM; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD TOXICITY; CONTROLLED STUDY; EDEMA; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ISOLATION; ENZYME PURIFICATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SNAKE; THROMBOCYTE AGGREGATION;

AMINO ACID SEQUENCE; ANALYSIS OF VARIANCE; ANIMALS; BOTHROPS; CHROMATOGRAPHY, ION EXCHANGE; CROTALID VENOMS; EDEMA; EPOPROSTENOL; HYDROGEN-ION CONCENTRATION; ISOELECTRIC FOCUSING; MALE; MICE; MOLECULAR SEQUENCE DATA; MUSCLES; PHOSPHOLIPASES A2; PLATELET AGGREGATION INHIBITORS; SEQUENCE ALIGNMENT; TEMPERATURE; TRANSCRIPTIONAL ACTIVATION;

BOTHROPS; BOTHROPS MOOJENI;

EID: 57049126480     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2008.08.020     Document Type: Article

References (51)

1. 2 from Bothrops jararacussu snake venom. Biochem. Pharmacol 64 (2002) 723-732
2. 2-A structural review. Toxicon 34 (1996) 827-841
3. Bozzola J.J., and Russell L.D. Electron Microscopy: Principles and Techniques for Biologists. second ed. (1998), Jones and Bartlett Publishers, Sudbury 670
4. Busse R., Hecker M., and Fleming I. Control of nitric oxide and prostacyclin synthesis in endothelial cells. Arzneimittelforschung 44 (1994) 392-396
5. 2 from the venom of Bothrops insularis (jararaca ilhoa). Biochimie 88 (2006) 1947-1959
6. França, F.O.S., Málaque, C.M.S., 2003. Acidente Botrópico. In: Animais Peçonhentos no Brasil: Biologia, Clínica e Terapêutica dos acidentes. pp. 72-86.
7. 2 isolated from Lachesis muta (Bushmaster) snake venom. Thromb. Haemost 78 (1997) 1372-1380
8. 2 isolated from Lachesis muta (Bushmaster) snake venom. Toxicon 38 (2000) 961-972
9. 2 isoenzyme isolated from Lachesis muta snake venom. Biochem. Pharmacol 63 (2002) 1589-1597
10. 2 isolated from Lachesis muta snake venom Comparison with lysophosphatidylcholine. Int. J. Biochem. Cell. Biol. 35 (2003) 1470-1481
11. 2 homologue myotoxin isolated from the venom of the snake Bothrops neuwiedi (yarará chica) from Argentina. Toxicon 37 (1999) 1735-1746
12. Gutiérrez J.M., Avila C., Rojas E., and Cerdas L. Alternative in vitro method for testing the potency of the polyvalent antivenom produced in Costa Rica. Toxicon 26 (1988) 411-413
13. 2) and tissue plasminogen activator (t-PA): alliance or neutrality. Pol. J. Pharmacol.47 (1995) 467-472
14. 2Enzymes: Structure, Function and Mechanism (1997), Wiley, Chichester 321-352
15. 2, notexin and taipoxin. Exp. Neurol 161 (2000) 517-526
16. Itzhaki R.F., and Gill D.M. A microbiuret method for estimating proteins. Anal. Biochem 9 (1964) 401-410
17. Jaffe E.A., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest 52 (1973) 2745-2756
18. 2 isoforms from Bothrops jararacussu snake venom. Biochimie 85 (2003) 983-991
19. 2enzymes: structure, function and mechanism (1997), Wiley, Chichester 369-387
20. 2 enzymes. Prostaglandins Other Lipid Mediat 68-69 (2002) 3-58
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
22. 2 homologue piratoxin-I in the rat and rabbit. Effect of polyanions and p-bromophenacyl. Biochem. Pharmacol 59 (2000) 1289-1294
23. 2 Engineering. Biochemistry 33 (1994) 14714-14722
24. 2: quaternary structure and inhibition mechanism insights. Biochem. Biophys. Res. Commun 311 (2003) 713-720
25. Magro A.J., Takeda A.A.S., Soares A.M., and Fontes M.R.M. Structure of BthA-I complexed with p-bromophenacyl bromide: possible correlations with lack of pharmacological activity. Acta Crystallogr. D 61 (2005) 1670-1677
26. 2 from Bothrops jararacussu venom complexed with p-bromophenacyl bromide. Acta Crystallogr. F 62 (2006) 600-603
27. 2 release by endothelial cells. Biochem. Pharmacol 72 (2006) 377-384
28. 2 from Bothrops alternatus (vibora de la cruz) venom. Purification and some characteristic properties. Toxicon 24 (1986) 259-272
29. 2 from the venom of the Brazilian snake Bothrops moojeni. Acta Crystallogr. D 57 (2001) 599-601
30. 2 proteins. Toxicon 37 (1999) 411-445
31. Pinho F.M.O., and Pereira I.D. Ofidismo. Rev. Assoc. Med. Bras 47 (2001) 24-29
32. 2 from Crotalus durissus collilineatus venom. J Protein Chem. 21 (2002) 131-136
33. 2 from the venom of the snake Bothrops moojeni (Caissaca). Mem. Inst. Butantan 51 (1989) 225-237
34. 2 from Bothrops jararacussu venom. Protein Journal 4 (2004) 273-285
35. 2 cDNA from Bothrops jararacussu venom gland. Protein Expr. Purif 37 (2004) 102-108
36. Rodrigues V.M., Soares A.M., Andriao-Escarso S.H., Franceschi A.M., Rucavado A., Gutierrez J.M., and Giglio J.R. Pathological alterations induced by neuwiedase, a metalloproteinase isolated from Bothrops neuwiedi snake venom. Biochimie 83 (2001) 471-479
37. 2 from Bothrops pauloensis snake venom. Toxicon 50 (2007) 153-165
38. Rosenberg D. The relationship between enzymatic activity and pharmacological properties of phospholipases in natural poisons. In: Harris J.B. (Ed). Natural Toxins Animal, Plant and Microbial (1986), Oxford Science Publications, Oxford 129-174
39. 2 genes and their expressions in Thai Russell's viper venom glands. Toxicon 52 (2008) 395-399
40. 2. Science 250 (1990) 1541-1546
41. 2 from the venom of Agkistrodon piscivorus piscivorus. J. Biol. Chem. 267 (1992) 22645-22657
42. 2, from the venom of the snake Bothrops jararaca: purification, primary structure analysis, and its characterization as a platelet-aggregation-inhibiting factor. Arch. Biochem. Biophys 367 (1999) 26-32
43. 2 with platelet aggregation inhibitor activity from Austrelaps superbus venom: protein purification and cDNA cloning. Arch. Biochem. Biophys 375 (2000) 289-303
44. 2 enzymes: classification and characterization. Biochim. Biophys. Acta 1488 (2000) 1-19
45. 2 from snake venoms: effects on catalytic and pharmacological properties. Toxicon 42 (2003) 855-868
46. 2 homologue from Bothrops jararacussu snake venom. Int. J. Biochem. Cell. Biol. 34 (2002) 668-677
47. 2 myotoxins from Bothrops snake venoms: structure-function relationship. Curr. Org. Chem. 8 (2004) 1677-1690
48. 2 in Bothrops moojeni venom: a promising approach to an enhanced antivenom production. Int. J. Biochem. Cell. Biol. 36 (2004) 258-270
49. 2 homologue from Bothrops pirajai venom. Biochimie 82 (2000) 245-250
50. 2. Role of histidine and calcium ion in the catalytic mechanism. Biochemistry 19 (1980) 743-750
51. Vesterberg O. Isoelectric focusing of proteins in polyacrylamide gels. Biochim. Biophys. Acta 257 (1972) 11-19